Cargando…
Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
While TRAIL is a promising anticancer agent due to its ability to selectively induce apoptosis in neoplastic cells, many tumors, including pancreatic ductal adenocarcinoma (PDA), display intrinsic resistance, highlighting the need for TRAIL-sensitizing agents. Here we report that TRAIL-induced apopt...
Autores principales: | Zhang, J-S, Herreros-Vilanueva, M, Koenig, A, Deng, Z, de Narvajas, A A-M, Gomez, T S, Meng, X, Bujanda, L, Ellenrieder, V, Li, X K, Kaufmann, S H, Billadeau, D D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067531/ https://www.ncbi.nlm.nih.gov/pubmed/24675460 http://dx.doi.org/10.1038/cddis.2014.102 |
Ejemplares similares
-
Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
por: Zhang, J-S, et al.
Publicado: (2014) -
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
por: Herreros-Villanueva, M, et al.
Publicado: (2013) -
Trafficking defects in WASH-knockout fibroblasts originate from collapsed endosomal and lysosomal networks
por: Gomez, Timothy S., et al.
Publicado: (2012) -
TRAIL-β and TRAIL-γ: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential
por: Krieg, A, et al.
Publicado: (2003) -
GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells
por: Wu, Yi-Ying, et al.
Publicado: (2018)